Drug ID: | NPD2614 |
Drug Name: | |
Molecular Formula: | C17H23NO4 |
Canonical SMILES: | NC[C@@H]1CC[C@H](CC1)C(=O)Oc1ccc(cc1)CCC(=O)O |
Standard InCHI: | InChI=1S/C17H23NO4/c18-11-13-1-6-14(7-2-13)17(21)22-15-8-3-12(4-9-15)5-10-16(19)20/h3-4,8-9,13-14H,1-2,5-7,10-11,18H2,(H,19,20)/t13-,14- |
Standard InCHIKey: | FHRSHSOEWXUORL-HDJSIYSDSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB010919 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 305.16 |
ALogP | -0.4004 |
MLogP | 2.78 |
XLogP | 2.749 |
HDA | 4 |
HBD | 2 |
Rotatable Bonds | 9 |
TPSA | 89.62 |
RO5 Violation | 0 |